Muscle Disease And Hypoglycemia: What's The Link?

Metabolic muscle disease is a group of conditions that can increase an individual's risk of cardiovascular disease, Type 2 diabetes, and stroke. It is often associated with insulin resistance, which can lead to elevated blood sugar levels and an increased risk of developing diabetes. While metabolic muscle disease itself is not commonly listed as a direct cause of hypoglycemia, there are several studies that have reported episodes of hypoglycemia in children with neuromuscular diseases and congenital muscle diseases. These episodes are typically triggered by prolonged fasting, illness, or increased physical activity, resulting in a situation where the body fails to maintain adequate glucose levels in the blood. Additionally, certain medications, critical illnesses, and organ failures are also known to cause hypoglycemia.

Explore related products

Hypoglycemia For Dummies

$13.5 $24.99

The Metabolic Effect Diet: Eat More, Work Out Less, and Actually Lose Weight While You Rest

$8.49 $18.99

Metabolic muscle disease and congenital muscular dystrophies

Congenital muscular dystrophy (CMD) refers to a group of muscular dystrophies that become apparent at or near birth. It is one of the variants of muscle weakness disorders presenting early in life during infancy and soon after birth. The difference between congenital myopathies and muscular dystrophies is that dystrophies are gradually progressive and are associated with increased muscle breakdown with age. Congenital myopathies signify disorders associated with muscle weakness in the neonatal age group, which could be secondary to genetic, metabolic, or other disorders.

CMD results in overall muscle weakness with possible joint stiffness or looseness. Depending on the type, CMD may involve spinal curvature, respiratory insufficiency, intellectual disabilities, learning disabilities, eye defects or seizures. CMD is caused by genetic mutations affecting some of the proteins necessary for muscles and sometimes for the eyes and or brain. The most common type of muscular dystrophy diagnosed in adulthood is myotonic dystrophy, which affects men and women equally. People with myotonic dystrophy experience difficulty relaxing their muscles after use. The condition can also affect the heart and lungs and may cause endocrine issues, such as thyroid disease and diabetes.

Duchenne muscular dystrophy is the most common type of congenital muscular dystrophy in children, with an incidence of around 1 in 3600 boys. The prevalence of specific types of congenital muscular dystrophies can also vary depending on the geographical area. For example, Fukuyama muscular dystrophy is the most common type in Japan.

Congenital muscle disease can cause hypoglycemia, with a few small studies reporting episodes of hypoglycemia in children with neuromuscular diseases. In one study, ten patients with CMD reported at least one episode of hypoglycemia beginning at an average age of 3.5 years. Symptoms included altered mental status and nausea/vomiting, and laboratory studies demonstrated metabolic acidosis and ketonuria, consistent with ketotic hypoglycemia. Patients with CMD may have an increased risk of hypoglycemia during fasting, illness, or stress due to their relatively low muscle mass.

Hypoglycemia and muscle mass

Hypoglycemia is a condition in which the body fails to maintain adequate levels of glucose in the blood. It is characterised by symptoms like hunger, sweating, shakiness, fatigue, weakness, and inability to think clearly. Severe hypoglycemia can cause confusion, seizures, and even coma. Hypoglycemia can be caused by diabetes medications, critical illness, organ failure, insulin-producing tumours, and certain surgeries. It can also be triggered by a high-carbohydrate meal, alcohol consumption, and specific medications like pentamidine and quinine.

Several studies have found an association between muscle mass and diabetes prevalence, independent of body fat distribution. Lower skeletal muscle mass is linked to a higher risk of diabetes, particularly in men. This relationship may be influenced by sex and race, with men generally having more muscle mass and a higher prevalence of type 2 diabetes than women. Additionally, women tend to have lower muscle mass but higher gynoid fat, which may offer protection against diabetes.

In terms of muscle mass and hypoglycemia, there is limited research available. However, some studies have reported episodes of hypoglycemia in children with congenital muscle diseases, such as muscular dystrophy. These children experienced symptoms like altered mental status, nausea, and vomiting, along with metabolic acidosis and ketonuria, indicating ketotic hypoglycemia. Their relatively low muscle mass may contribute to a higher risk of hypoglycemia during fasting, illness, or stressful situations.

While there is a suggested inverse association between skeletal muscle mass and blood glucose levels, more comprehensive research is needed to establish a direct link between muscle mass and hypoglycemia. Further studies should also explore the potential impact of sex and race on this relationship, as these factors may influence the association between muscle mass and diabetes prevalence.

In summary, while the exact connection between muscle mass and hypoglycemia requires further investigation, current evidence suggests that lower muscle mass may be a contributing factor to hypoglycemia in individuals with congenital muscle diseases. Additionally, the association between muscle mass and diabetes prevalence highlights the potential role of muscle mass in blood glucose regulation.

Hypoglycemia and fasting

Hypoglycemia is a condition that occurs when a person's blood glucose level drops below the normal limit, which is less than 70 mg/dL. This condition is closely related to fasting, especially in people with diabetes or other health problems related to blood sugar levels.

People with diabetes who reduce their food intake or develop chronic kidney disease are more likely to experience hypoglycemia. Older adults are more susceptible than younger people to hypoglycemia resulting from sulfonylurea medications. If a person with diabetes eats less than usual after taking their medication, the medication may lower their blood glucose level too much. Certain medications, such as pentamidine and quinine, can also cause hypoglycemia.

In people with congenital muscle disease, hypoglycemic episodes are typically triggered by prolonged periods of fasting, illness, stress, or increased physical activity. These episodes are associated with symptoms such as increased fatigue, decreased alertness, altered mental status, and nausea/vomiting.

To prevent hypoglycemia while fasting, it is important to monitor your blood sugar levels regularly and stay hydrated. Eat foods rich in complex carbohydrates, such as whole wheat bread, brown rice, potatoes, and vegetables, and avoid sugary foods and drinks. Avoid strenuous exercise, as it can accelerate the decrease in blood sugar levels. If you experience symptoms of hypoglycemia, immediately check your blood sugar level and consume foods or drinks containing carbohydrates.

Hypoglycemia and medication

Hypoglycemia, or low blood sugar, is often caused by excess insulin, whether due to the body producing too much naturally or as a result of injecting too much synthetic insulin. Hypoglycemia is a common occurrence in people with diabetes, especially those who take insulin to manage their condition. In fact, one study found that 4 in 5 people with Type 1 diabetes and almost half of all people with Type 2 diabetes who take insulin reported a low blood sugar episode at least once over a four-week period.

People with Type 2 diabetes who take meglitinide or sulfonylurea oral diabetes medications are also at an increased risk of low blood sugar. Older adults are more susceptible to hypoglycemia resulting from sulfonylurea medications. If, after taking a dose of a medication for diabetes, a person eats less than usual or is more physically active than normal, the medication may lower the level of glucose in the blood too much. People with type 1 diabetes or long-standing type 2 diabetes (at least 10 years) are more prone to hypoglycemia in these situations because they may not produce enough glucagon or epinephrine to counteract low blood glucose levels.

Certain medications other than those for diabetes, such as pentamidine, used to treat a form of pneumonia that occurs as part of AIDS, and quinine, used to treat muscle cramps, can occasionally cause hypoglycemia. An uncommon type of medication-related hypoglycemia occurs in people who secretly take insulin or other diabetes medications as part of a psychological disorder such as factitious disorder imposed on self (previously called Munchausen syndrome).

In rare cases, hypoglycemia can be caused by an insulin-producing tumour in the pancreas. It can also occur after bariatric surgery, such as gastric bypass surgery, where sugars are absorbed very quickly, stimulating excess insulin production.

Hypoglycemia and metabolic abnormalities

Hypoglycemia is most often caused by medications, particularly those taken to control diabetes. Less common causes include other medications, critical illness, organ failure, a reaction to carbohydrates, an insulin-producing tumour in the pancreas, and certain types of surgery. In non-diabetic adult patients, hypoglycaemia may be related to drugs, critical illness, cortisol or glucagon insufficiency, non-islet cell tumours, or insulinoma.

Inherited metabolic diseases in adults can also cause hypoglycemia. These include congenital disorders of glycosylation, fatty acid oxidation disorders, and glycogen storage disorders (GSD). GSDs exclusively affecting the metabolism of muscle glycogen can cause myopathy and/or cardiomyopathy. Hepatic glycogen storage disorders causing hypoglycemia include GSD I, III, VI, IX, GSD 0, and Fanconi-Bickel syndrome.

In children, inborn errors of metabolism (IEM) are considered a differential diagnosis in cases of hypoglycemia. In adulthood, IEM-related hypoglycemia can persist in a previously diagnosed childhood disease. Hypoglycemia may sometimes be the presenting sign of IEM, with signs including short stature, hepatomegaly, hypogonadism, dysmorphia, or muscular symptoms.

Hypoglycemic episodes in patients with congenital muscle disease are typically associated with clinical symptoms, ranging from increased fatigue to decreased alertness. These episodes are often associated with profound metabolic abnormalities consistent with a ketotic hypoglycemic state. They are typically triggered by prolonged fasting or situations of increased glucose demand, such as illness or physical activity.

Metabolic syndrome, a group of conditions that increase the risk of cardiovascular disease, Type 2 diabetes, and stroke, can also contribute to insulin resistance. Factors that contribute to insulin resistance include excess abdominal weight, lack of physical activity, and excess visceral fat.

Frequently asked questions